Creation and validation of a predictive framework for evaluating recurrence risk in patients with pyogenic liver abscess caused by Klebsiella pneumoniae - Top-Institutions - MDSpire

Creation and validation of a predictive framework for evaluating recurrence risk in patients with pyogenic liver abscess caused by Klebsiella pneumoniae

  • By

  • Liyong Zhang

  • Jiaqi Chen

  • Yihao Qu

  • Yuwei Fu

  • Kai Chen

  • Jinhua Cui

  • Jian Li

  • Aijun Yu

  • December 31, 2025

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    The University of Hong Kong
    The University of Hong Kong

    Hong Kong, N/A

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Microbiology

  • #2

    National University of Singapore (NUS) Yong Loo Lin School of Medicine
    National University of Singapore (NUS) Yong Loo Lin School of Medicine

    Singapore, N/A

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Clinical Epidemiology

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Clinical Research

  • #4

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, N/A

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Gastroenterology

Original Source(s)

Creation and validation of a predictive framework for evaluating recurrence risk in patients with pyogenic liver abscess caused by Klebsiella pneumoniae

  • by Liyong Zhang, Jiaqi Chen, Yihao Qu, Yuwei Fu, Kai Chen, Jinhua Cui, Jian Li, Aijun Yu

  • December 31, 2025

Related Content

Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study

The Role of IFI27 in Modulating Regulatory T Cell Activity Contributes to Lung Injury in Sepsis Through IL-10/STAT3 Pathway

Investigation of ACOD1 Levels in Sepsis Patients: Correlations with Disease Severity and Immune Profiles